Clincosm LogoSign in Get a demo

Lymphoma, Follicular

Showing 26 - 50 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Follicular Trial in Worldwide (SAIT101, MabThera®)

Completed
Has Results
  • Lymphoma, Follicular
  • SAIT101
  • MabThera®
  • Whittier, California
  • +24 more
Sep 14, 2020

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (Oral Azacitidine, Rituximab, cyclophosphamide)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Follicular
  • Oral Azacitidine
  • +4 more
  • Tampa, Florida
  • +6 more
Aug 26, 2020

Follicular Lymphoma ThroughProspective Collection of Data

Completed
  • Lymphoma, Follicular
    • Chicago, Illinois
    • +50 more
    Jul 7, 2020

    Lymphoma, Follicular Trial in Worldwide (Ofatumumab, Bendamustine infusion, Ofatumumab and Bendamustine infusions (Arm A))

    Terminated
    Has Results
    • Lymphoma, Follicular
    • Tucson, Arizona
    • +139 more
    Mar 25, 2020

    Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

    Completed
    Has Results
    • Lymphoma, Non-Hodgkin
    • +6 more
    • Duarte, California
    • +41 more
    Mar 4, 2020

    Lymphoma, Follicular Trial (Rituxan, CT-P10, Cyclophosphamide)

    Completed
    Has Results
    • Lymphoma, Follicular
    • Rituxan
    • +4 more
    • (no location specified)
    Jan 19, 2020

    Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

    Completed
    Has Results
    • Acute Leukemia
    • +8 more
    • Tacrolimus (ARM with Methotrexate)
    • +7 more
    • Duarte, California
    • +29 more
    Jan 2, 2019

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in Worldwide (Part 1 (Dose

    Terminated
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +4 more
    • Part 1 (Dose Escalation): Duvortuxizumab
    • Part 2 (Dose Expansion): Duvortuxizumab
    • Detroit, Michigan
    • +19 more
    Dec 19, 2018

    Lymphoma, Follicular Trial in Germany, United States (Enzastaurin)

    Completed
    Has Results
    • Lymphoma, Follicular
    • Casa Grande, Arizona
    • +22 more
    Oct 4, 2018

    Lymphoma, Follicular Trial in Worldwide (BI 695500, MabThera)

    Completed
    Has Results
    • Lymphoma, Follicular
    • Canberra, Migration Data, Australia
    • +28 more
    Sep 3, 2018

    Positron Emission Tomography-Scan in Evaluation of High Tumor

    Completed
    • Lymphoma, Follicular
      • Besançon, France
      • +21 more
      Aug 21, 2018

      Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

      Terminated
      • Lymphoma, Large B-Cell, Diffuse
      • +20 more
      • ASN002 Dose Escalation
      • ASN002 RD
      • Tempe, Arizona
      • +13 more
      Aug 13, 2018

      Lymphoma, Follicular, Stem Cell Transplantation Trial in France (Reduced_intensity conditioning)

      Completed
      • Lymphoma, Follicular
      • Stem Cell Transplantation
      • Reduced_intensity conditioning
      • Angers Cedex 01, Angers, France
      • +25 more
      Aug 8, 2018

      Lymphoma, Mantle-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in Worldwide (Daratumumab)

      Terminated
      Has Results
      • Lymphoma, Mantle-Cell
      • +2 more
      • Duarte, California
      • +34 more
      May 28, 2018

      Lymphoma, Follicular Trial in Worldwide (inotuzumab ozogamicin, rituximab, cyclophosphamide)

      Terminated
      Has Results
      • Lymphoma, Follicular
      • inotuzumab ozogamicin
      • +7 more
      • Mission Hills, California
      • +38 more
      Dec 8, 2017

      Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States

      Completed
      Has Results
      • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
      • +5 more
      • Haploidentical Bone Marrow Transplantation
      • GVHD prophylaxis
      • Duarte, California
      • +16 more
      Nov 28, 2017

      Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial (Duvortuxizumab, Ibrutinib)

      Withdrawn
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +3 more
      • (no location specified)
      Nov 22, 2017

      Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in United States (SGN-CD19A)

      Completed
      • Burkitt Lymphoma
      • +4 more
      • Birmingham, Alabama
      • +5 more
      Oct 17, 2017

      Rituximab in Combination With Chemotherapy in

      Completed
      Has Results
      • Lymphoma, Follicular
      • Belgrade, Serbia
      • +5 more
      Jun 26, 2017

      Lymphoma, Follicular Trial (Follicular Lymphoma)

      Completed
      Has Results
      • Lymphoma, Follicular
      • Follicular Lymphoma
      • (no location specified)
      Jun 9, 2017

      Lymphoma, Non-Hodgkin, Lymphoma, Follicular Trial in Dzerzhinsk, Moscow (Aurixim)

      Completed
      • Lymphoma, Non-Hodgkin
      • Lymphoma, Follicular
      • Dzerzhinsk, Russian Federation
      • +2 more
      May 22, 2017

      Study Drug-Rituximab and Alpha Interferon

      Completed
      • Lymphoma, Follicular
      • Follow up
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre, Odette Cancer Centre
      Mar 17, 2017

      Adult DLBCL, Mantle Cell Lymphoma Recurrent, Lymphoma, Follicular Trial in Rochester (Doxycycline)

      Terminated
      Has Results
      • Adult Diffuse Large B-Cell Lymphoma
      • +8 more
      • Rochester, New York
        University of Rochester
      Oct 27, 2016

      MabThera/Rituxan (Rituximab) in Follicular Lymphoma

      Terminated
      • Lymphoma, Follicular
        • Athens, Greece
        • +3 more
        Nov 1, 2016

        Lymphoma, Follicular Trial in Worldwide (Rituximab)

        Completed
        • Lymphoma, Follicular
        • Buenos Aires, Argentina
        • +61 more
        Nov 1, 2016